Skip to main content
Erschienen in: Journal of Translational Medicine 1/2014

Open Access 01.12.2014 | Editorial

Pain, Critical Care and Anesthesia section

verfasst von: Yasin Said AlMakadma

Erschienen in: Journal of Translational Medicine | Ausgabe 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

No abstract

Editorial

As we are witnessing major technological and informatics progress on a daily basis, the emphasis on translational approach in medical research has become not only clearly needed but also practically achievable. In addition, very closely linked fields such as Anesthesia, Pain Medicine and Critical Care may benefit mostly of the development and consolidation of translational medicine. From its "bench to bedside" and beyond, in the community, translational medicine touches the real goal of research which is to understand in order to correctly and adequately apply. Changes in the way we provide patients' medical care require rigorous process and thorough analytical work so to reach the stage of implementing policies and strategies on the wider population.
Acute Respiratory Distress Syndrome (ARDS) is an example of how focus on translational research may lead to a better understanding of the disease. Defining ARDS continues to remain a challenge but it is also an essential step before including patients in ARDS related clinical trials. The clinical definition of ARDS and its diagnostic criteria have been subject to few revisions since the disease was initially described, in 1967, by Ashbaugh DG et al [1]. In 1994 the American European Consensus Criteria were used to redefine the disease [2]. However, ARDS was more recently reviewed again by the definition of the Berlin Consensus [3],[4]. Despite of all these attempts, it remains true, however, that up to 50% of patients included in ARDS-related randomized trials may well be false positives. This would explain why over 200 randomized clinical trials had failed to identify consistent conclusions on therapeutic interventions as explained in the editorial of S. Fröhlich et al. who conclude that without specific biomarker, it is unlikely to make real progress in tackling this deadly disease [5]. On the other hand understanding and treating pain syndromes, such as Complex Regional Pain Syndrome (CRPS), still long way far from done. CRPS diagnosis relies mainly on bedside criteria and subjective findings and descriptions by both the patient and the physician [6],[7]. Whether we consider "sensory sympathetic coupling", "cortical re-organization" related to CRPS, underlying local mechanisms and genes translation in familial "CRPS" cases remain all to apprehend. Findings of Functional MRI are an example of how translational approach may well be of great value. Focused translational research may thus help us identifying biomarker(s) for the disease so that we may be able to start its management earlier and perhaps have less disabling outcome.
The concept of "Translational Medicine" represents a significant milestone in our journey towards better knowing and better managing diseases and towards better understanding how specific molecules, such as anaesthetics, anti-neuropathic and neuromodulation techniques such as Spinal Cord Stimulation affect the nervous system among others. This is why we are launching this section, Pain, Critical Care and Anaesthesia, "PCA", of the Journal of Translational Medicine in which we welcome multidisciplinary contributions from colleagues interested in these areas of expertise.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet. 1967, 2: 319-323. 10.1016/S0140-6736(67)90168-7.CrossRefPubMed Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet. 1967, 2: 319-323. 10.1016/S0140-6736(67)90168-7.CrossRefPubMed
2.
Zurück zum Zitat Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: Report of the American-European Consensus Conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care. 1994, 9 (1): 72-81. 10.1016/0883-9441(94)90033-7.CrossRefPubMed Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: Report of the American-European Consensus Conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care. 1994, 9 (1): 72-81. 10.1016/0883-9441(94)90033-7.CrossRefPubMed
3.
Zurück zum Zitat Thompson BT, Matthay MA: "The Berlin sefinition of ARDS versus pathological evidence of diffuse alveolar damage". Am J Respir Crit Care Med. 2013, 187 (7): 675-677. 10.1164/rccm.201302-0385ED.CrossRefPubMed Thompson BT, Matthay MA: "The Berlin sefinition of ARDS versus pathological evidence of diffuse alveolar damage". Am J Respir Crit Care Med. 2013, 187 (7): 675-677. 10.1164/rccm.201302-0385ED.CrossRefPubMed
4.
Zurück zum Zitat Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012, 307: 2526-2533.PubMed Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012, 307: 2526-2533.PubMed
5.
Zurück zum Zitat Fröhlich S, Murphy N, Boylan JF: ARDS: progress unlikely with non-biological definition. Br J Anaesth. 2013, 111 (5): 696-699. 10.1093/bja/aet165.CrossRefPubMed Fröhlich S, Murphy N, Boylan JF: ARDS: progress unlikely with non-biological definition. Br J Anaesth. 2013, 111 (5): 696-699. 10.1093/bja/aet165.CrossRefPubMed
6.
Zurück zum Zitat Bruehla S, Hardena RN, Galerb BS, Saltza S, Bertramc M, Backonjad M, Gaylese R, Rudinf N, Bhugrag MK, Stanton-Hicks M: External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. Pain. 1999, 81 (1–2): 147-154. 10.1016/S0304-3959(99)00011-1.CrossRef Bruehla S, Hardena RN, Galerb BS, Saltza S, Bertramc M, Backonjad M, Gaylese R, Rudinf N, Bhugrag MK, Stanton-Hicks M: External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. Pain. 1999, 81 (1–2): 147-154. 10.1016/S0304-3959(99)00011-1.CrossRef
7.
Zurück zum Zitat Norman Hardena R, Bruehlb S, Perezc RSGM, d'Birkleine F, Marinusd J, f'Maihofnerg C, Lubenowh T, Buvanendranh A, Mackeyi S, Graciosaa J, Mogilevskia M, Ramsdena C, Chontb M, Vatinej JJ: Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain. 2010, 150 (2): 268-274. 10.1016/j.pain.2010.04.030.CrossRef Norman Hardena R, Bruehlb S, Perezc RSGM, d'Birkleine F, Marinusd J, f'Maihofnerg C, Lubenowh T, Buvanendranh A, Mackeyi S, Graciosaa J, Mogilevskia M, Ramsdena C, Chontb M, Vatinej JJ: Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain. 2010, 150 (2): 268-274. 10.1016/j.pain.2010.04.030.CrossRef
Metadaten
Titel
Pain, Critical Care and Anesthesia section
verfasst von
Yasin Said AlMakadma
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe 1/2014
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-014-0268-0

Weitere Artikel der Ausgabe 1/2014

Journal of Translational Medicine 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.